NCT06548386 Feasibility and Accuracy of a Novel Pleural Drain Gas Analyzer in Detecting Air Leaks
| NCT ID | NCT06548386 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lung Healing Technologies Inc |
| Condition | Air Leak From Lung |
| Study Type | INTERVENTIONAL |
| Enrollment | 33 participants |
| Start Date | 2025-02-05 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 33 participants in total. It began in 2025-02-05 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to assess the clinical feasibility of a novel, reusable, low cost gas analyzer that detects breath in chest drains in order to diagnose and heal air leaks. The investigators have developed prototype gas analyzers that attach to the outlet of any analog chest drain, and can be connected temporarily to the sampling port. They detect breath by measuring CO2, O2, and pressure, in order to supplement the information provided by the bubbles in the water seal.
Eligibility Criteria
Inclusion Criteria: 1. Patients who are scheduled for thoracic surgery and expected to have chest tube placed 2. For patients who are unable to sign consent, but meet all of the inclusion criteria and none of the exclusion criteria, a legally appointed representative (LAR) will be allowed to sign consent for that patient 3. Patients that provide informed consent for the study 4. Patients \>18 years old Exclusion Criteria: 1. Patients with hemodynamic instability 2. Pregnant patients 3. Prisoners 4. Individuals who are not yet adults
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06548386 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Air Leak From Lung. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06548386 currently recruiting?
Yes, NCT06548386 is actively recruiting participants. Contact the research team at ddodd@lunghealingtechnologies.com for enrollment information.
Where is the NCT06548386 trial being conducted?
This trial is being conducted at Evanston, United States.
Who is sponsoring the NCT06548386 clinical trial?
NCT06548386 is sponsored by Lung Healing Technologies Inc. The trial plans to enroll 33 participants.